Protein concerted motions in the DNA-human topoisomerase I complex

Nucleic Acids Research

Volumn 31, Issue 5, 2003, Pages 1525-1535

  Chillemi, Giovanni ^c   Fiorani, Paola ^a,b   Benedetti, Piero ^b   Desideri, Alessandro ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DNA TOPOISOMERASE; DOUBLE STRANDED DNA;

BASE PAIRING; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; DNA CLEAVAGE; DNA STRAND; DOWNSTREAM PROCESSING; ENZYME ACTIVE SITE; HUMAN; MOLECULAR DYNAMICS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW;

BINDING SITES; COMPUTER SIMULATION; DNA; DNA TOPOISOMERASES, TYPE I; HUMANS; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 0037338421     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg242     Document Type: Review

References (45)

1. Redinbo,M.R., Stewart,L., Kuhn,P., Champoux,J.J. and Hol,W.G.J. (1998) Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science, 279, 1504-1513.
2. Stewart,L., Redinbo,M.R., Qiu,X., Hol,W.G.J. and Champoux,J.J. (1998) A model for the mechanism of human topoisomerase I. Science, 279, 1534-1541.
3. Pommier,Y., Pourquier,P., Fan,Y. and Strumberg,D. (1998) Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta, 1400, 83-106.
4. Redinbo,M.R., Stewart,L., Champoux,J.J. and Hol,W.G.J. (1999) Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures. J. Mol. Biol., 292, 685-696.
5. Redinbo,M.R., Champoux,J.J. and Hol,W.G.J. (2000) Novel insight into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. Biochemistry, 39, 6832-6840.
6. Lesher,D.-T.T., Pommier,Y., Stewart,L. and Redinbo,M.R. (2002) 8-Oxoguanine rearranges the active site of human topoisomerase I. Proc. Natl Acad. Sci. USA, 99, 12102-12107.
7. Pommier,Y., Pourquier,P., Urasaki,Y., Wu,J. and Laco,G.S. (1999) Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resistance Updates, 2, 307-318.
8. Ozols,R.F. (2000) Optimum chemotherapy for ovarian cancer. Int. J. Gynecol. Cancer, 10, 33-37.
9. Saltz,L.B., Cox,J.V., Blanke,C., Rosen,L.S., Fehrenbacher,L., Moore,M.J., Maroun,J.A., Ackland,S.P., Locker,P.K., Pirotta,N., Elfring,G.L. and Miller,L.L. (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N. Engl. J. Med., 343, 905-914.
10. Castrignanò,T., Chillemi,G. and Desideri,A. (2000) Structure and hydration of BamHI DNA recognition site: a molecular dynamics investigation. Biophys. J., 79, 1263-1272.
11. Cheatham,T.E. and Kollman,P.A. (2000) Molecular dynamics simulation of nucleic acids. Annu. Rev. Phys. Chem., 51, 435-471.
12. Norberg,J. and Nilsson,L. (2002) Molecular dynamics applied to nucleic acids. Acc. Chem. Res., 35, 465-472.
13. Castrignanò,T., Chillemi,G., Varani,G. and Desideri,A. (2002) Molecular dynamics simulation of the RNA complex of a double-stranded RNA-binding domain revels dynamic features of the intermolecular interface and its hydration. Biophys. J., 83, 3542-3552.
14. Chillemi,G., Castrignanò,T. and Desideri,A. (2001) Structure and hydration of the DNA-human topoisomerase I covalent complex. Biophys. J., 81, 490-500.
15. Reyes,C.M. and Kollman,P.A. (1999) Molecular dynamics study of U1A-RNA complexes. RNA, 5, 235-244.
16. Giudice,E. and Lavery,R. (2002) Simulations of nucleic acids and their complexes. Acc. Chem. Res., 35, 350-357.
17. McCammon,J.A. and Harvey,S.C. (1987) Dynamics of Proteins and Nucleic Acids. Cambridge University Press, London, UK.
18. Garcia.,A.E. (1992) Large amplitude nonlinear motions in proteins. Phys. Rev. Lett., 68, 2696-2699.
19. Amadei,A., Linssen,A.B.M. and Berendsen,H.J.C. (1993) Essential dynamics of proteins. Proteins, 17, 412-425.
20. Kitao,A. and Go,N. (1999) Investigating protein dynamics in collective coordinate space. Curr. Opin. Struct. Biol., 9, 164-169.
21. Berendsen,H.J.C. and Hayward,S. (2000) Collective protein dynamics in relation to function. Curr. Opin. Struct. Biol., 10, 165-169.
22. Cornell,W.D., Cieplak,P., Bayly,C.I., Gould,I.R., Kenneth,M., Merz,J., Ferguson,D.M., Spellmeyer,D.C., Fox,T., Caldwell,J.W. and Kolman,P.A. (1995) A second generation force field for the simulation of proteins, nucleic acids and organic molecules. J. Am. Chem. Soc., 117, 5179-5197.
23. Jorgensen,W.L., Chandrasekhar,J., Madura,J.D., Impey,R.W. and Klein,M.L. (1983) Comparison of simple potential functions for simulating liquid water. J. Chem. Phys., 79, 926-935.
24. Darden,T., York,D. and Pedersen,L. (1993) Particle mesh Ewald-an N.log(n) method for Ewald sums in large systems. J. Chem. Phys., 98, 10089-10092.
25. Cheatham,T.E., Miller,J.L., Fox,T. Darden,T.A. and Kollman,P.A. (1995) Molecular dynamics simulation on solvated biomolecular systems: the particle mesh Ewald method leads to stable trajectories of DNA, RNA and proteins. J. Am. Chem. Soc., 117, 4193-4194.
26. Ryckaert,J.-P., Ciccotti,G. and Berendsen,H.J.C. (1977) Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys., 23, 327-341.
27. Berendsen,H.J.C., Postma,J.P.M., van Gusteren,W.F., Di Nola,A. and Haak,J.R. (1984) Molecular dynamics with coupling to an external bath. J. Comput. Phys., 81, 3684-3690.
28. Berendsen,H.J.C., van der Spoel,D. and van Drunen,R. (1995) GROMACS-a message-passing parallel molecular-dynamics implementation. Comp. Phys. Comm., 95, 43-56.
29. Humphrey,W., Dalke,A. and Shulten,K. (1996) VMD-visual molecular dynamics. J. Mol. Graph., 14, 33-38.
30. Chillemi,G., Falconi,M., Amedei,A., Zimatore,G., Desideri,A. and Di Nola,A. (1997) The essential dynamics of Cu, Zn superoxide dismutase: suggestion of intersubunit communication. Biophys. J., 73, 1007-1018.
31. Falconi,M., Stroppolo,M.E., Cioni,P., Strambini,G., Sergi,A., Ferrario,M. and Desideri,A. (2001) Dynamics-function correlation in Cu, Zn superoxide dismutase: a spectroscopic and molecular dynamics simulation study. Biophys. J., 80, 2556-2567.
32. Redinbo,M.R., Champoux,J.J. and Hol,W.G.J. (1999) Structural insights into the function of type IB topoisomerases. Curr. Opin. Struct. Biol., 9, 29-36.
33. Urasaky,Y., Laco,G.S., Pourquier,P., Takebayashi,Y., Kohlhagen,G., Gioffre,C., Zhang,H., Chatterjee,D. and Pantazis,P. (2001) Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line. Cancer Res., 61, 1964-1969.
34. Benedetti,P., Fiorani,P., Capuani,L. and Wang,J.C. (1993) Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res., 53, 4343-4348.
35. Rubin,E., Pantazis,P., Bharti,A., Toppmeyer,D., Giovannella,B. and Kufe,D. (1994) Identification of a mutant topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin. J. Biol. Chem., 269, 2433-2439.
36. Li,X.G., Haluska,P., Hsiang,Y.-H., Bharti,A.K., Kufe,D.W., Liu,L.F. and Rubin,E.H. (1997) Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis. Biochem. Pharmacol., 53, 1019-1027.
37. Fiorani,P., Amatruda,J.F., Silvestri,A., Butler,R.H., Bjornsti,M.-A. and Benedetti,P. (1999) Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity. Mol. Pharmacol., 56, 1105-1115.
38. Bailly,C., Carrasco,C., Hamy,F., Vezin,H., Prudhomme,M., Saleem,A. and Rubin,E. (1999) The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles. Biochemistry, 38, 8605-8611.
39. Saleem,A., Ibrahim,N., Patel,M., Li,X.G., Gupta,E., Mendoza,J., Pantazis,P. and Rubin,E.H. (1997) Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning. Cancer Res., 57, 5100-5106.
40. Tamura,H., Kohchi,C., Yamada,R., Ikeda,T., Koiwai,O., Patterson,E., Keene,J.D., Okada,K., Kjeldsen,E., Nishikawa,K. and Andoh,T. (1991) Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites. Nucleic Acids Res., 19, 69-75.
41. Van der Spoel,D. and Berendsen,H.J.C. (1997) Molecular dynamics simulations of Leu-Enkephalin in water and DMSO. Biophys. J., 72, 2032-2041.
42. Berman,H.M., Westbrook,J., Feng,Z., Gilliland,G., Bhat,T.N., Weissig,H., Shindyalov,I.N. and Bourne,P.E. (2000) The Protein Data Bank. Nucleic Acids Res., 28, 235-242.
43. Laco,G.S., Collins,J.R., Luke,B.T., Kroth,H., Sayer,J.M., Jerina,D.M. and Pommier,Y. (2002) Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model. Biochemistry, 41, 1428-1435.
44. Staker,B.L., Hjerrild,K., Feese,M.D., Behnke,C.A., Burgin,A.B. and Stewart,L. (2002) The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc. Natl Acad. Sci. USA, 99, 15387-15392.
45. Arcangeli,C., Bizzarri,A.R. and Cannistraro,S. (2001) Concerted motions in copper plastocyanin and azurin: an essential dynamics study. Biophys. Chem., 90, 45-56.